Drug Profile
Levobetaxolol - Lee''s Pharmaceuticals
Alternative Names: Levobetaxolol hydrochloride - Lee's PharmaceuticalsLatest Information Update: 26 May 2023
Price :
$50
*
At a glance
- Originator Lee's Pharmaceutical
- Class Antiglaucomas; Propanolamines; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ocular hypertension; Open-angle glaucoma
Most Recent Events
- 01 Nov 2017 No development reported - Phase-III for Ocular hypertension in China (Ophthalmic) (NCT02617459)
- 01 Nov 2017 No development reported - Phase-III for Open-angle glaucoma in China (Ophthalmic) (NCT02617459)
- 01 Nov 2015 Phase-III clinical trials in Open-angle glaucoma and Ocular hypertension in China (Ophthalmic) (NCT02617459)